Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn:
”Plasma-Derived Medicinal Products (PDMPs) are life-saving therapies used to treat a wide range of medical conditions, including immune deficiencies, bleeding disorders, and various rare diseases.
These products are derived from human plasma, which can be collected in two ways: by separating it from donated whole blood (Recovered Plasma) or through a dedicated plasma donation process (Source Plasma).
The manufacturing of PDMPs involves a highly specialized and strictly regulated process called plasma fractionation, where different plasma proteins are separated and purified for therapeutic use.
Since plasma is the primary raw material for these products, ensuring its high quality and safety is of utmost importance.”
Stay informed on all coming webinars and seminars in Hematology with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis